Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
0.9215
+0.0203 (2.25%)
At close: Aug 12, 2026, 4:00 PM EDT
0.9215
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:10 PM EDT
Lite Strategy Market Cap
Lite Strategy has a market cap or net worth of $31.35 million as of August 12, 2026. Its market cap has decreased by -2.63% in one year.
Market Cap
31.35M
Enterprise Value
23.81M
1-Year Change
-2.63%
Ranking
Category
Stock Price
$0.92
ChartMarket Cap Chart
Since December 18, 2003, Lite Strategy's market cap has decreased from $424.10M to $31.35M, a decrease of -92.61%. That is a compound annual growth rate of -10.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 31.30M | -35.60% |
| Dec 31, 2025 | 48.60M | 196.34% |
| Dec 31, 2024 | 16.40M | -57.51% |
| Dec 29, 2023 | 38.60M | 18.77% |
| Dec 30, 2022 | 32.50M | -89.20% |
| Dec 31, 2021 | 301.00M | 1.31% |
| Dec 31, 2020 | 297.10M | 62.62% |
| Dec 31, 2019 | 182.70M | -2.72% |
| Dec 31, 2018 | 187.80M | 141.70% |
| Dec 29, 2017 | 77.70M | 46.60% |
| Dec 30, 2016 | 53.00M | -2.93% |
| Dec 31, 2015 | 54.60M | -40.85% |
| Dec 31, 2014 | 92.30M | -46.40% |
| Dec 31, 2013 | 172.20M | 580.63% |
| Dec 31, 2012 | 25.30M | 105.69% |
| Dec 30, 2011 | 12.30M | 73.24% |
| Dec 31, 2010 | 7.10M | -86.19% |
| Dec 31, 2009 | 51.40M | - |
| Dec 31, 2008 | 51.40M | -74.17% |
| Dec 31, 2007 | 199.00M | 2.58% |
| Dec 29, 2006 | 194.00M | -45.49% |
| Dec 30, 2005 | 355.90M | -30.12% |
| Dec 31, 2004 | 509.30M | -23.48% |
| Dec 31, 2003 | 665.60M | 56.94% |
| Dec 18, 2003 | 424.10M | - |
View and export this data all the way back to 2003. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lantern Pharma | 34.28M |
| Dyadic International | 32.43M |
| BeyondSpring | 31.83M |
| Estrella Immunopharma | 31.74M |
| NanoViricides | 31.55M |
| Genenta Science | 31.02M |
| Enlivex | 30.53M |
| Quince Therapeutics | 30.48M |